Bacterial Antigen Ingredients TRIZ Cases

Engineering exopolysaccharide-associated proteins converts harmful biofilm contamination into a versatile scaffold that localizes vaccine antigens on surfaces.

TruCulture immune profiling identifies predictive biomarkers to avoid ineffective anti-TNF therapy and reduce adverse side effects.

Replacing expensive machinery with simple ionic crosslinking enables cost-effective production of mucoadhesive alginate capsules.

Immunogenic composition combining OspA fragments with OspC phylotype peptides to induce protective immune responses in dogs.

Harvesting and purifying patient-specific lymphocytes from excised spleen tissue to reduce post-splenectomy infection risks caused by immune deficiency.

SLAM polypeptides export target proteins to the bacterial surface, addressing antibiotic resistance and variable vaccine efficacy in Neisseria infections.

Nucleic acid vaccines encoding S. aureus antigens stimulate specific immunity, preventing resistant strain development without antibiotic pressure.

Isolated Klebsiella outer membrane proteins induce specific antibodies, resolving adverse reactions from lipopolysaccharide-containing vaccines.

LEAP2 antibodies block ghrelin-induced GHSR activity to suppress appetite and lower glucose levels in wasting syndrome treatment.

Aliivibrio probiotic bacteria administered via water replace antibiotics to prevent microbial infections and boost fish survival rates.

Modified rodent hepadnavirus core antigens diminish carrier-specific antibody production through targeted B-cell epitope removal.

Chorismate mutase antigens combined with immune adjuvants strengthen Th1 cell-mediated responses to overcome limited BCG efficacy in adults.

Natural deep-eutectic solvents stabilize live Mollicutes bacteria in liquid form, eliminating costly freeze-drying and cold-chain logistics.

Heterologous enzymes synthesize rhamnose polysaccharides in E. coli, replacing labor-intensive extraction with high-yield production.

Isolating C. difficile surface proteins FIgG, FIgE, and FIgK prevents bacterial colonization without triggering toxin-related side effects.

Alginate and poly-L-lysine coating shields anthrax spores from gastric juices, enabling practical wildlife vaccination without injection.

Mutant FhbB chimeras block bacterial Factor H binding to stop immune dysregulation and periodontal disease.

A recombinant BCG strain induces superior immune responses through phagolysosomal escape mechanisms.

Hydrophobic patch-free recombinant protein nanoparticles maintain thermal stability and stimulate high affinity antibodies without adjuvants.

Segmented LcrV proteins reduce immunosuppressive side effects while maintaining vaccine efficacy.

Adsorbing detoxified pneumolysin onto aluminium phosphate adjuvants using optimized pH and ratio conditions.

Recombinant M protein epitopes stimulate protective antibody and T cell responses, preventing autoimmune reactions triggered by rheumatic fever.

Inducible expression of truncated PspA1 resolves the trade-off between vaccine efficacy and coverage by replacing universal carriers.

Identified conserved outer membrane antigens raise robust immune responses against non-typeable Haemophilus influenzae strains.

Bacteroides fragilis outer membrane vesicles activate ATG16L1-dependent pathways to suppress mucosal inflammation in inflammatory bowel disease.

Thermosensitive hydrogel transitions to gel at body temperature, sustaining antigen release to boost antibody titers without frequent booster shots.

Segmented foreign antigen vaccination overcomes tumor immune evasion and instability.

Multi-gene mutations in rpoD, FecR, ATP-grasp, and FtsH genes create an avirulent strain that prevents Salmon Rickettsial Syndrome without reversion risk.

Urease-deficient BCG strain overcomes treatment failure by eliminating urea hydrolysis and restoring effective immune response.

Ad5-YFV adenovirus vector vaccine overcomes pre-existing immunity to induce robust mucosal protection against pneumonic plague.

Inactivating LytM proteins in Gram-negative bacteria boosts outer membrane vesicle production and modifies protein content to enhance vaccine efficacy.

Composite nanoparticles with bacterial membrane coatings overcome antibiotic resistance by inducing durable antibody responses against pathogens.

Segmented BoNT/B peptides detect anti-toxin antibodies, reducing immunoresistance that limits Botulinum neurotoxin therapy efficacy.

Circular polyribonucleotides encode coronavirus antigens to stimulate polyclonal antibody production.

Novel Lactobacillus plantarum AMT14 strain produces antibacterial substances to inhibit pathogens.

Reduced-repeat IgM protease antigen closes heterologous protection gaps across multiple Streptococcus suis serotypes, ensuring reliable piglet immunity.

Administering Lactococcus lactis subsp. cremoris ATCC 19257 lowers serum cholesterol and protects cells from ionizing radiation damage.

Deleting amino acids 180 to 400 from flagellin removes immunogenic regions, lowering inflammatory responses and liver toxicity without losing TLR5 binding.

Neutrophil inhibitors in vaccine compositions enhance IgA antibody production by B lymphocytes.

Przewalski bacterial cultures ferment mammalian milk to produce bioactive peptides that strengthen immune function and digestive health in immature mammals.

Incorporate infected peripheral lymph nodes into ground meat to mimic commercial pathogen distribution and test contamination interventions.

Inducible promoters regulate transporter expression in engineered microbes, maintaining viability while enhancing therapeutic efficacy.

Computational segmentation of the EHEC proteome identifies high-priority antigens, reducing bacterial colonization in murine models.

Clostridium perfringens enterotoxin targets claudin receptors to kill chemotherapy-resistant ovarian and uterine tumors while sparing healthy tissue.

Vaccine generates antibodies targeting deacetylated PNAG structures, preventing impermeable biofilms that resist antibiotics.

Quil-A and DOTAP self-assemble into spherical nanostructures to protect mRNA from enzymatic degradation while activating immune cells.

Inactivated HIV virus particles carrying Gag and Pol epitopes combine with Lactobacillus plantarum to resolve vaccine failure by inducing immunotolerance.

Assay detects rough and smooth Mycobacterium tuberculosis morphotypes using selective binding molecules to differentiate active from latent infections.

Vaccine uses surfome-derived antigens to reduce bacterial loads, bypassing antibiotic resistance and side effects.